FDA Approved: NUPLAZID — Original Application (Acadia Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved NUPLAZID (pimavanserin tartrate) for the first time, marking the drug's original approval for Parkinson disease psychosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Psychosis

Drugs mentioned

• Nuplazid (Pimavanserin)

Snippet

ORIG AP for NUPLAZID (PIMAVANSERIN TARTRATE)